Chemoembolization and radioembolization for hepatocellular carcinoma

Riad Salem*, Robert J. Lewandowski

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

71 Scopus citations


Hepatocellular carcinoma (HCC) continues to represent a major worldwide problem. Although treatments such as resection, transplantation, and ablation may provide a chance for a cure, these options are often precluded because of advanced disease presentation. Palliative treatments include transarterial embolization and systemic therapies. This review will summarize the state of the science for embolic therapies in HCC (conventional and drug-eluting chemoembolization, radioembolization) as well as discuss related topics including HCC staging, assessment of response, and ongoing clinical trials.

Original languageEnglish (US)
Pages (from-to)604-611
Number of pages8
JournalClinical Gastroenterology and Hepatology
Issue number6
StatePublished - Jun 2013


  • Chemoembolization
  • Hepatocellular Carcinoma
  • Radioembolization

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology


Dive into the research topics of 'Chemoembolization and radioembolization for hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this